Pier Giorgio Natali Selected Research

Pier Giorgio Natali Research Topics

Disease

60	Neoplasms (Cancer) 10/2022 - 07/2002
26	Carcinoma (Carcinomatosis) 01/2012 - 07/2002
22	Melanoma (Melanoma, Malignant) 11/2017 - 09/2002
14	Ovarian Neoplasms (Ovarian Cancer) 12/2014 - 08/2002
12	Breast Neoplasms (Breast Cancer) 07/2019 - 02/2004
9	Carcinogenesis 06/2010 - 12/2005
8	Neoplasm Metastasis (Metastasis) 07/2019 - 08/2002
5	Hypoxia (Hypoxemia) 04/2014 - 08/2002
4	Neuroblastoma 01/2012 - 08/2003
3	Ovarian Epithelial Carcinoma 12/2014 - 06/2010
3	Melanosis (Freckles) 03/2011 - 01/2009
3	Sunburn 03/2011 - 01/2009
2	Prostatic Neoplasms (Prostate Cancer) 03/2023 - 05/2004
2	Colorectal Neoplasms (Colorectal Cancer) 07/2015 - 01/2008
2	Colonic Neoplasms (Colon Cancer) 07/2015 - 01/2008
2	Adenocarcinoma 08/2013 - 08/2008
2	Testicular Neoplasms (Testicular Cancer) 05/2008 - 04/2006
2	Ascites 06/2006 - 08/2002
1	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 03/2023
1	Triple Negative Breast Neoplasms 02/2017

Drug/Important Bio-Agent (IBA)

24	Endothelin-1 (Endothelin 1)IBA 04/2014 - 08/2002
16	Proteins (Proteins, Gene)FDA Link 02/2017 - 08/2002
15	Endothelin A ReceptorIBA 12/2014 - 11/2002
10	LigandsIBA 04/2021 - 08/2003
10	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2014 - 08/2002
9	Endothelins (Endothelin)IBA 04/2014 - 01/2004
9	AtrasentanIBA 04/2006 - 08/2002
7	Messenger RNA (mRNA)IBA 10/2010 - 08/2002
7	AntigensIBA 09/2010 - 07/2002
6	Epidermal Growth Factor (EGF)IBA 11/2017 - 03/2006
6	AntibodiesIBA 04/2014 - 05/2004
6	Peptides (Polypeptides)IBA 01/2014 - 05/2004
6	ZD4054IBA 04/2011 - 06/2006
5	Biomarkers (Surrogate Marker)IBA 07/2019 - 02/2004
5	Endothelin Receptors (Endothelin Receptor)IBA 03/2013 - 08/2002
5	ErbB Receptors (EGF Receptor)IBA 01/2010 - 11/2004
4	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 02/2007 - 07/2004
4	ProstaglandinsIBA 02/2007 - 07/2004
4	Complementary DNA (cDNA)IBA 06/2006 - 09/2002
4	Peptide Hydrolases (Proteases)FDA Link 06/2006 - 08/2002
3	Vascular Endothelial Growth Factor CIBA 04/2014 - 03/2009
3	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 03/2013 - 02/2009
3	Cadherins (E-Cadherin)IBA 01/2012 - 11/2004
3	Sunscreening Agents (Sunscreens)IBA 03/2011 - 01/2009
3	MART-1 AntigenIBA 09/2010 - 01/2009
3	VaccinesIBA 09/2010 - 01/2009
3	Endothelin B ReceptorIBA 06/2010 - 02/2004
3	Paclitaxel (Taxol)FDA LinkGeneric 06/2010 - 11/2004
3	beta CateninIBA 02/2009 - 11/2004
3	Mitogen-Activated Protein KinasesIBA 07/2007 - 11/2004
3	Indicators and Reagents (Reagents)IBA 03/2006 - 09/2002
3	Connexin 43 (Connexin43)IBA 11/2004 - 10/2003
2	AntioxidantsIBA 03/2023 - 05/2005
2	Immunoconjugates (Immunoconjugate)IBA 04/2021 - 11/2017
2	Phenobarbital (Luminal)FDA Link 07/2019 - 01/2008
2	CateninsIBA 07/2015 - 01/2012
2	Conditioned Culture MediaIBA 04/2014 - 01/2012
2	Small Interfering RNA (siRNA)IBA 04/2014 - 03/2009
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 04/2014 - 08/2010
2	HLA Antigens (Human Leukocyte Antigens)IBA 01/2014 - 09/2011
2	Dacarbazine (DIC)FDA LinkGeneric 09/2010 - 01/2009
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 09/2010 - 03/2009
2	beta-ArrestinsIBA 08/2010 - 02/2009
2	integrin-linked kinaseIBA 08/2010 - 04/2006
2	taxaneIBA 06/2010 - 05/2003
2	human ERBB2 proteinIBA 01/2010 - 03/2006
2	Cancer VaccinesIBA 03/2009 - 01/2009
2	Growth Factor ReceptorsIBA 02/2009 - 02/2007
2	Protein Isoforms (Isoforms)IBA 08/2008 - 03/2007
2	Progesterone Receptors (Progesterone Receptor)IBA 07/2007 - 03/2006
2	Caspase 3 (Caspase-3)IBA 07/2007 - 06/2006
2	Decitabine FDA Link 03/2007 - 04/2006
2	Endothelin-3 (Endothelin 3)IBA 02/2007 - 11/2004
2	EnzymesIBA 01/2007 - 11/2004
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2007 - 11/2004
2	PolyphenolsIBA 06/2006 - 06/2006
2	TeaIBA 06/2006 - 06/2006
2	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 06/2006 - 06/2006
2	Tyrosine (L-Tyrosine)FDA Link 06/2006 - 10/2003
2	Proto-Oncogene Proteins c-kit (Proto-Oncogene Protein c-kit)IBA 01/2005 - 08/2003
2	Stem Cell FactorIBA 01/2005 - 08/2003
2	Dinoprostone (PGE2)FDA Link 11/2004 - 11/2004
2	A 192621IBA 11/2004 - 02/2004
2	Cyclooxygenase 1IBA 11/2004 - 07/2004
1	Acetylcysteine (Siran)FDA LinkGeneric 03/2023
1	CytokinesIBA 03/2023
1	Complement System Proteins (Complement)IBA 03/2023
1	Immune Checkpoint ProteinsIBA 01/2019
1	Phosphotransferases (Kinase)IBA 11/2017
1	Frizzled ReceptorsIBA 02/2017
1	macitentanIBA 12/2014
1	ArrestinIBA 12/2014
1	HLA-G Antigens (HLA G)IBA 01/2014
1	HLA-A Antigens (HLA-A)IBA 01/2014
1	HLA-B Antigens (HLA-B)IBA 01/2014
1	HLA-C Antigens (HLA-C)IBA 01/2014
1	Formaldehyde (Formol)FDA Link 08/2013

Therapy/Procedure

16	Therapeutics 04/2021 - 11/2002
8	Immunotherapy 10/2022 - 04/2006
5	Drug Therapy (Chemotherapy) 12/2014 - 02/2004